• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Aspivix's Carevix Cervical Stabilizer Gains FDA OK

    Apyx Medical Submits 510(k) App for Renuvion APR Handpiece

    LivaNova Releases SenTiva DUO VNS for Drug-Resistant Epilepsy

    CGM Devices Could Become Main Glucose Monitoring Solution in U.S.

    New Device Developed to Non-Invasively Measure Cervical Nerve Activity
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Forefront Medical Technology

    Medbio LLC

    Arthur G. Russell Co. Inc., The

    LEMO USA Inc.

    Halkey-Roberts Corporation
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Onshoring Medical Device Manufacturing Can Strengthen Supply Chains

    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Forefront Medical Technology

    Medbio LLC

    Arthur G. Russell Co. Inc., The

    LEMO USA Inc.

    Halkey-Roberts Corporation
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Improved Outcomes Proven With Insulet’s Omnipod 5 System

    Studies show the automated insulin delivery system improved HbA1c nearly one percentage point in kids and 0.60 percent in adolescents and adults.

    Related Content
    • MEDICAL & BIOTECH MANUFACTURING
    • MDI
    • JK Medirise-Disposable Medical Device Company
    • sfm medical devices GmbH
    • BMP Medical - Delivering Custom Plastics Manufactured Solutions
    Business Wire09.16.21
    Insulet Corporation, a global developer of tubeless insulin pump technology with its Omnipod brand of products, has announced promising results from its latest pivotal trial for the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) in very young children. Omnipod 5, the world’s first tubeless, wearable automated insulin delivery (AID) system that continuously adapts insulin delivery based on glucose levels and trends, significantly improved time in range and reduced HbA1c in children aged 2 through 5.9 years with type 1 diabetes. 
     
    “Managing type 1 diabetes in very young children is particularly challenging due to their unpredictable eating patterns, erratic physical activity, and an increased fear of hypoglycemia from caregivers, since these patients often cannot self-treat or verbalize their symptoms,” said Dr. Trang Ly MBBS, FRACP, Ph.D., Insulet senior vice president and medical director. “Omnipod 5 has tremendous potential to improve outcomes and ease of use for our youngest patients, and we are delighted to share these pivotal trial results.”
     
    Omnipod 5 Preschool Pivotal Study Overview
    Insulet enrolled a group of 80 preschool aged children across 10 U.S. sites for this study. The participants, who were between 2 and 5.9 years of age with an HbA1c of under 10 percent, used Omnipod 5 at home for a period of three months after a 14-day period using their standard therapy, which included either pump therapy or multiple daily injections (MDI). The children were unrestricted in eating and exercise throughout the study.
     
    The study showed an overall reduction in HbA1c from an average of 7.4 percent to 6.9 percent, and a significant increase in time in range (70-180 mg/dL), from an average of 57.2 percent to 68.1 percent, or an additional 2.6 hours per day. Median time in hypoglycemia (<70 mg/dL) was reduced, from 2.2 percent to 1.9 percent overall.
     
    In addition, parents and caregivers of study participants reported improved sleep quality as assessed by the Pittsburgh Sleep Quality Index (PSQI),1 a questionnaire considered to be the gold standard in measuring subjective sleep quality. Parents and caregivers reporting “very good” or “fairly good” sleep increased from 65 percent at baseline to 90 percent at the end of the study.
     
    “These results are impressive, not only for our youngest patients, but also for their families,” said Dr. Jennifer Sherr, principal investigator and associate professor, Yale University School of Medicine. “Diabetes is a team sport—all members of the family are impacted, often with far-reaching consequences. Caregivers often have poor sleep quality as they strive for safety, with ensuing fatigue that affects family dynamics. These results show that Omnipod 5 can have a positive impact on the entire family.”
     
    It is also noteworthy that 100 percent of the preschool pivotal trial participants opted to continue using Omnipod 5 in a 12-month extension phase, which demonstrates their overall satisfaction with the system and the clinical outcomes achieved.
     
    Additional Omnipod 5 Data 
    Insulet also shared additional results from the Omnipod 5 pivotal study in people aged 6 through 70 years with type 1 diabetes, including clinical outcomes after transitioning from MDI, extension study results with six months of system use, and quality of life and user satisfaction data:
    • Transition from MDI to Omnipod 5 Improves HbA1c
    • The 33 participants in the pivotal trial transitioning from MDI to Omnipod 5 achieved significant improvement in HbA1c (children: 7.73 percent to 6.74 percent, adolescents and adults: 7.57 percent to 6.97 percent) and time in range (children: 52.2 percent to 68.9 percent; adolescents and adults: 60.4 percent to 72.3 percent) after three months of use. These results support the feasibility of transitioning directly from MDI to automated insulin delivery with Omnipod 5.
     
    Improved Glycemic Outcomes Over Six Months With Omnipod 5
    A total of 224 pivotal study participants continuing use of Omnipod 5 in an extension study demonstrated sustained improvements in HbA1c over a total of six months of system use. Pediatric results decreased from an average of 7.7 percent at baseline to 6.9 percent at six months, and the adolescent and adult cohort decreased from an average of 7.2 percent to 6.7 percent. The extension study also revealed sustained improvements in time in range with minimal time below range.
     
    Adults, Adolescents, and Caregivers Report Improved System Usability, Satisfaction, and Quality of Life with Omnipod 5
    Equally as important as the glycemic outcomes are the results describing Omnipod 5 usability, user satisfaction, and impact on quality of life from the pivotal trial. Users reported significantly improved scores with the System Usability Scale following three months of Omnipod 5 use, with a mean baseline score of 75.9, 79.4 and 77.5 out of a maximum of 100 to a final score of 83.8, 86.3 and 89 for adults, teens, and caregivers of children, respectively. These results demonstrate that users perceived Omnipod 5 to be a more usable product compared to their prior therapy.

    Adults and caregivers of teens and children also reported increased satisfaction with their treatment as measured by the Insulin Delivery Satisfaction Survey and the Diabetes Treatment Satisfaction Questionnaire, suggesting that Omnipod 5 may alleviate some of the burdens associated with existing treatment options for type 1 diabetes both for adults and caregivers of younger users.
     
    Furthermore, Omnipod 5 led to significant improvements in quality-of-life measures, including reductions in diabetes-related distress across all groups, and improved hypoglycemic confidence among adults and caregivers of children. As indicated by these outcomes, reduced diabetes distress and improved quality of life are key benefits of using the Omnipod 5 AID system that are complementary to the glycemic benefits achieved.
     
    Omnipod System and Omnipod DASH Improve Clinical Outcomes in Children and Adults Living with Type 1 Diabetes
    Insulet also presented data related to the company’s non-AID insulin delivery system products, the Omnipod System and Omnipod DASH System, both currently available in the United States, Canada, and in several international markets. In the largest adult cohort study of 13,389 people with type 1 diabetes initiating therapy with the Omnipod System or Omnipod DASH System in the United States to date, HbA1c was reduced significantly (-0.8 percent), which was achieved with an 18 percent reduction in daily insulin dosage and a reduction in self-reported hypoglycemia from three episodes to 1.6 episodes per week. Similar results were seen in an analysis in 6,034 children, which included data from children below the age of 2 years.
     
    The Omnipod 5 System received breakthrough device designation from the U.S. Food and Drug Administration and is currently under review. The company expects to launch Omnipod 5 in the United States in limited release during the second half of 2021.

    Reference 
    1 The Pittsburgh Sleep Quality Index: A New Instrument for Psychiatric Practice and Research (Authors Daniel J. Buysse, Charles F. Reynolds III, Timothy H. Monk, Susan R. Berman, and David J Kupfer, © 1989 and 2010, University of Pittsburgh. All rights reserved.)
    Suggested For You
    MEDICAL & BIOTECH MANUFACTURING MEDICAL & BIOTECH MANUFACTURING
    MDI MDI
    JK Medirise-Disposable Medical Device Company JK Medirise-Disposable Medical Device Company
    sfm medical devices GmbH sfm medical devices GmbH
    BMP Medical - Delivering Custom Plastics Manufactured Solutions BMP Medical - Delivering Custom Plastics Manufactured Solutions
    High Tech Turning Co. Inc. High Tech Turning Co. Inc.
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform
    Turner Imaging Systems Announces International Expansion Turner Imaging Systems Announces International Expansion
    RedDress’ ActiGraft System Receives New FDA Clearance RedDress’ ActiGraft System Receives New FDA Clearance
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021 MedTech Innovator Names the Finalists for the Title of MedTech Innovator 2021
    Boston Scientific Agrees to Acquire Devoro Medical Boston Scientific Agrees to Acquire Devoro Medical
    CareDx Appoints Hannah Valantine to its Board CareDx Appoints Hannah Valantine to its Board
    CE Mark Granted to Predictive Software for Kidney Allograft Survival CE Mark Granted to Predictive Software for Kidney Allograft Survival
    Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech

    Related Literature / Brochures

    • MEDICAL & BIOTECH MANUFACTURING

      ISO 13485:2016 • FDA Registered

    • MDI

      ...
      Katie Johnson, Marketing Manager 11.17.22

    • JK Medirise-Disposable Medical Device Company

      ...
      Ketan Munjani, Marketing Manager 11.17.22


    • sfm medical devices GmbH

      ...
      Albert Busch, Head of Marketing 11.11.22

    • BMP Medical - Delivering Custom Plastics Manufactured Solutions

      BMP Medical - Delivering Custom Plastics Manufactured Solutions

      Medical Contract Manufacturing, Design, Assembly & Packaging

    Loading, Please Wait..

    Trending
    • Study: Smartphone Therapeutic Helps Improve Fibromyalgia In Patients
    • The Future Of Biomedical Engineering Advancements
    • Environmental Sustainability Becoming Increasingly Important To Medtech Industry
    • Medtronic's Recall Of Mahurkar Catheters Is Class I
    • A New Approach To Post-Market Surveillance
    Breaking News
    • Aspivix's Carevix Cervical Stabilizer Gains FDA OK
    • Apyx Medical Submits 510(k) App for Renuvion APR Handpiece
    • LivaNova Releases SenTiva DUO VNS for Drug-Resistant Epilepsy
    • CGM Devices Could Become Main Glucose Monitoring Solution in U.S.
    • New Device Developed to Non-Invasively Measure Cervical Nerve Activity
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOED Elects New Board Officers for 2023
    Aspire Hires Darrec Jones as VP of Business Development
    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
    Coatings World

    Latest Breaking News From Coatings World

    PPG Completes COLORFUL COMMUNITIES Project in Denmark
    10 Partners of the Automotive Industry Form JV, Cofinity-X
    BASF Recognized as Top Company for Supplier Diversity
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Aspivix's Carevix Cervical Stabilizer Gains FDA OK
    Apyx Medical Submits 510(k) App for Renuvion APR Handpiece
    LivaNova Releases SenTiva DUO VNS for Drug-Resistant Epilepsy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bionova Expansion Project to Quadruple GMP Biologics Manufacturing Capacity
    Steriline Provides Fill-Finish Solution for Berkshire Sterile Manufacturing
    Merck Revenues up 22% for the Year to $59.3B
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Mielle Unveils Haircare Bundles Inspired by Amazon Original Series Harlem
    Kering Appoints Former L’Oréal and Estée Lauder Exec as CEO of Kering Beauté
    Paco Rabanne, Fashion & Perfume Designer, Dies
    Happi

    Latest Breaking News From Happi

    Elf Cosmetics Grows Net Sales By 49% in Q3
    Sally Beauty Holdings Reports Net Sales of $957 Million in Q1 Results
    Murad and Active Minds To Combat Health Epidemic of Stress
    Ink World

    Latest Breaking News From Ink World

    Roland DGA Announces Key Changes to Leadership Team
    Ball Reports 2022 Results
    3D Printing Materials Market Worth $7.9 Billion by 2027: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Polytag develops new UV tag reading technology
    Enterprise Print Group adds Screen Truepress Jet L350UV SAI E
    Rotocon announces wine label design competition
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Kimberly-Clark Supports Period Poverty Initiative in Australia
    Suominen Reports Q4, Full Year Results
    Qvin Menstrual Blood Diagnostic Device Receives FDA Approval in Thailand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Toetal Solutions Secures $1.8 Million in New Financing
    Adrian Tyndall Joins Axogen's Board of Directors
    ADSM-Synchro Medical Acquired by Tyber Medical
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Zebra Provides East West Shrine Bowl with RFID Tracking Technology
    AAAS Elects Three ORNL Scientists as Fellows
    Flex Recognized as One of Fortune World’s Most Admired Companies 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login